Your browser doesn't support javascript.
loading
[Elimination of the left atrial appendage in the prevention of thromboembolic events in patients with atrial fibrillation].
Gancarczyk, Urszula; Przewlocki, Tadeusz; Podolec, Piotr; Komar, Monika.
Afiliação
  • Gancarczyk U; Klinika Chorób Serca i Naczyn, Instytut Kardiologii UJ CM, Krakowski Szpital Specjalistyczny im. Jana Pawla II, Kraków, Polska.
  • Przewlocki T; Klinika Chorób Serca i Naczyn, Instytut Kardiologii UJ CM, Krakowski Szpital Specjalistyczny im. Jana Pawla II, Kraków, Polska.
  • Podolec P; Klinika Chorób Serca i Naczyn, Instytut Kardiologii UJ CM, Krakowski Szpital Specjalistyczny im. Jana Pawla II, Kraków, Polska.
  • Komar M; Klinika Chorób Serca i Naczyn, Instytut Kardiologii UJ CM, Krakowski Szpital Specjalistyczny im. Jana Pawla II, Kraków, Polska.
Wiad Lek ; 72(9 cz 2): 1829-1833, 2019.
Article em Pl | MEDLINE | ID: mdl-31622274
ABSTRACT
Atrial fibrillation (AF) is the most common cardiac arrhythmia in the adult population. Thromboembolic events are one of the reson of increased mortality in this group of patients. Oral anticoagulation therapy significantly reduces the risk of complications, however every tenth patient has contraindications to this treatment. Percutaneous left atrial appendage occlusion (LAAO) is effective, non-pharmacological method of treatment through elimination the source of thromi. This procedure is dedicated to patients with high risk of thromboembolism events and contraindications to anticoagulation.
Assuntos
Palavras-chave
Buscar no Google
Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Tromboembolia / Apêndice Atrial Limite: Humans Idioma: Pl Ano de publicação: 2019 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Tromboembolia / Apêndice Atrial Limite: Humans Idioma: Pl Ano de publicação: 2019 Tipo de documento: Article